100th General Assembly, 2nd Regular Session

HB 2052

  
Adds provisions relating to pharmaceutical cost transparency.
Sponsor: Sain, Matt (014)
Proposed Effective Date: 8/28/2020
LR Number: 4150H.01I
Last Action: 05/15/2020 - Referred: Health and Mental Health Policy(H)
Bill String: HB 2052
Next House Hearing: Hearing not scheduled
Calendar: Bill currently not on a House calendar

Bill Text

4150H.01I

Bill Summary

Bill Summary
HB2052I